FloridaMarijuana.net

OCTOBER 9, 2018

In 2017, The National Academies of Sciences, Engineering, and Medicine published a statement that the use of cannabis for the treatment of pain is supported by “well-controlled clinical trials and that there is substantial evidence that cannabis is an effective treatment for chronic pain in adults.”.

Terpenes 100

Terpenes Chronic Pain Strains Clinical Trials 100

Cannabis Law Report

JULY 28, 2021

Validates Cepharanthine’s potential in treating various cancers with unsatisfactory treatment options. Advance to FDA IND-enabling studies to support human clinical studies. Previously the Company announced that it had secured FDA Orphan Drug Designation for cepharanthine in the treatment of esophageal cancer.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Cannabis Law Report

JULY 1, 2021

Clinical trials repeatedly demonstrate their promise for treating mood, anxiety, and substance use disorders. In 2017, the FDA designated MDMA a breakthrough therapy for post-traumatic stress disorder, and in 2018 the agency identified psilocybin as a breakthrough for treatment-resistant depression.

Law 59

Law Policy Research and Development Clinical Trials 59

The Joint Blog

JUNE 2, 2020

The study, titled Pharmacokinetics, efficacy, and safety of a novel selective-dose cannabis inhaler in patients with chronic pain: A randomized, double-blinded, placebo-controlled trial , was first published by NORML. Participants inhaled a precise dose containing either THC (at doses of either 0.5mg or 1mg) or placebo.

Chronic Pain 58

Chronic Pain Clinical Trials Safety Marijuana 58

Healer

MARCH 26, 2021

Gresh has joined a growing number of patients who swear by medical cannabis not only as a treatment option for chronic pain, but also as a substitute for prescription opioids used in pain management. They’re an effective treatment for pain, but they’re not great for chronic pain, and many people are reluctant to start on opioids,” he said.

Chronic Pain 86

Chronic Pain Clinical Trials Treatment Patients 86

Project CBD

FEBRUARY 28, 2023

CBD first appeared on the natural channel’s top 40 list in 2017, ranking 12th, after sales growth of more than 300% from the previous year. million more on CBD products in 2021 compared to 2017 — a 413.4% Medical cannabinoids for treatment of neuropsychiatric symptoms in dementia: A systematic review. increase in annual sales.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

NOVEMBER 29, 2019

Different legislation across EU countries on prescribing cannabis-based medicines can hinder patients’ access to their treatment when they travel abroad, EUMCA said. Our main priority is informing national and EU institutions about the opportunity that this treatment is offering,” said Sita Schubert, secretary general of EUMCA.

Medicine 59

Medicine Clinical Trials Treatment Access 59

Veriheal

JUNE 7, 2021

It turns out that this blissful drug, MDMA, has the potential to be used effectively as a treatment for certain conditions- some of which are in urgent need of effective medical assistance. . MDMA has also reportedly been used with over 1,000 individuals in clinical trials , with no adverse effects to report. . What is MDMA?

Therapy 92

Therapy Treatment Conditions Clinical Trials 92

FloridaMarijuana.net

AUGUST 13, 2018

There are a variety of treatment options to help patients cope with and heal from anxiety disorders. The research Men’s Journal is referring to is the 2017 journal article published in Clinical Psychology Review titled: Medical cannabis and mental health : A guided systematic review. Medications can be used along with therapy.

Marijuana 145

Marijuana Patients Clinical Trials Conditions 145

Cannabis Law Report

MAY 29, 2019

“The licence enables our strategic alliance with RMIT to advance on its objective to establish a world first library of cannabis medicines, as well as conducting ground-breaking pre-clinical research into the positive effects that medicinal cannabis may have on specific cancers.”.

Cultivation 40

Cultivation Pharmaceutical Clinical Trials Extraction 40

Peninsula Alternative Health

MAY 15, 2019

Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. Of 272 combined patients, 86% experienced some clinical benefit, and 10% experienced a complete clinical response. tetrahydrocannabinol (THC).

Conditions 40

Conditions Therapy Cannabinoids Epilepsy 40

Canna Law Blog

MARCH 4, 2020

From 2015 to 2018, the number of clinics increased from 60 to 300; that number is undoubtedly higher today. People are increasingly using ketamine for ailments that resist treatment through traditional pharmaceutical drugs. Ketamine is also widely known as a popular party drug (“ Special K “).

Therapy 93

Therapy Legalization Chronic Pain DEA 93

CannaMD

NOVEMBER 6, 2019

In addition, data from the 2017 National Survey on Drug Use and Health showed a potential inverse relationship between marijuana and opioid use, based on data that reported a drop of opioid misuse from 2016 to 2017 (from 11.8 Medical cannabis is an effective and safe alternative for pain treatment. million to 11.4 Get Started.

Marijuana 88

Marijuana Patients Clinical Trials Data 88

Cannabis Law Report

AUGUST 26, 2019

Over the years, research has generated results to suggest that marijuana benefits in the treatment of some conditions. The approval is based on the research and clinical trials. However, a study published in 2017 found that the use of CBD results in fewer seizures among children with Dravet syndrome, as compared to placebo.

Chronic Pain 45

Chronic Pain Clinical Trials Epilepsy Conditions 45

The Joint Blog

FEBRUARY 18, 2020

The findings suggest that some ADHD patients may consume cannabis as a “substitute treatment” for more conventional medications, authors concluded. METHODS: Participants were adult patients licensed for medical cannabis (MC) treatment who also reported a diagnosis of ADHD by a physician.

Clinical Trials 45

Clinical Trials Terpenes Data Cannabinoids 45

Alchimia

FEBRUARY 1, 2022

Neuroprotective : could contribute to the treatment of neurodegenerative diseases such as multiple sclerosis. It should be noted that the levels of transaminases rose at the start of treatment with cannabidiol but returned to normal values ??over It follows that if this is maintained over time, damage to this organ could be caused.

CBD 52

CBD Epilepsy Research and Development Cannabinoids 52

Cannabis Law Report

NOVEMBER 29, 2019

For instance, THC has shown the potential to help in the treatment of conditions like PTSD, depression, eating disorders, and epilepsy. These include the potential to relieve symptoms like nausea and vomiting in cancer patients after undergoing chemotherapy treatment. THC has also been touted as a potential treatment for cancer.

Oil 104

Oil THC Cannabinoids Research and Development 104

CannaMD

AUGUST 26, 2020

Current Cocaine Treatments. As researchers point out: There is no gold standard pharmacological treatment for dependence on cocaine. Although several drugs have been investigated, there is no strong or consistent evidence indicating any of these drugs for the treatment of cocaine use disorder. mice/rats).

Therapy 98

Therapy CBD Research and Development Treatment 98

Cannabis Law Report

DECEMBER 17, 2021

deletion syndrome clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases. The trial is currently registered with the Australian New Zealand Clinical Trials Registry (ANZCTR).

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical Therapy 52

Cannabis Law Report

DECEMBER 7, 2021

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The popularity of medical cannabinoids (MCs) treatment is growing, as more countries enable MCs treatment for various indications in adults 1. Metrics details. Introduction. Search strategy. 18 years old).

Safety 52

Safety Cannabinoids Events Data 52

United Patients Group

JANUARY 5, 2023

A 2017 review of 10 clinical trials found that people who took probiotics had a 14% lower risk of contracting a cold or flu. He adds that research has shown that probiotics can help the immune system produce more antibodies to fight off viruses and bacteria. Probiotics May Reduce Flu Risk.

Digestion 105

Digestion Research and Development Food Strains 105

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions. Based on my clinical experience, it is rare for people to experience CBD-drug interactions at doses below 100mg daily. . 2017): 1586-1592. Gaston, Tyler E., Epilepsia 58.9

CBD 98

CBD THC Conditions Medicine 98

Cannabis Law Report

SEPTEMBER 1, 2019

The Victorian and New South Wales Governments had both begun clinical trials of cannabis products for children with severe epilepsy and for palliative care, respectively. The clinical trials and the standard of production could lead the world.”. Around the country, the nascent industry’s march is gathering pace.

Clinical Trials 53

Clinical Trials Research and Development Medicine Cultivation 53

FloridaMarijuana.net

AUGUST 15, 2018

According to a 2017 report published by the National Academies of Sciences , PTSD is a stressor-related disorder which develops as a result of a patient’s exposure to a traumatic event. Treatment usually aims at reducing reactions and to diminishing the acuity of the reactions. Get your Florida Medical Marijuana Card.

Treatment 182

Treatment Marijuana Research and Development Therapy 182

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions.[1]. Based on my clinical experience, it is rare for people to experience CBD-drug interactions at doses below 100mg daily. [2]. The Journal of Clinical Pharmacology 60.4

CBD 52

CBD THC Conditions Medicine 52

Green Relief

MAY 13, 2018

As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. Treatment modalities for TBI are limited with few satisfactory pharmaceutical options available. Writing in 2017, Mayo Clinic neurologist Eugene L. A promiscuous compound.

THC 64

THC CBD Cannabinoids Research and Development 64

Cannabis Law Report

JULY 12, 2019

Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. IMAJ, FEBRUARY 2017.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Cannabis Law Report

JULY 9, 2021

Not only are more and more jurisdictions decriminalizing the use of psychedelics for recreational purposes, but it appears that psychedelic substances are the new horizon for the treatment of severe psychological disorders and other ailments. Since then, “ketamine clinics” have proliferated throughout the U.S., Id ; 21 CFR 312.1-10;

Law 105

Law Therapy Clinical Trials Research and Development 105

Green Relief

MAY 12, 2018

As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. Treatment modalities for TBI are limited with few satisfactory pharmaceutical options available. Writing in 2017, Mayo Clinic neurologist Eugene L. A promiscuous compound.

Research and Development 40

Research and Development Cannabinoids Therapy CBD 40

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. For over three decades, we’ve been working to achieve mass mental health throughout the United States, Canada, and Europe.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

MAY 29, 2022

Widespread approval for psychedelic treatments remains unlikely, but the tide is slowly turning. In 2019, FDA approved Spravato (esketamine) nasal spray for treatment of depression in adults. [8] In 2017, FDA granted a request for Breakthrough Therapy designation for MDMA to treat PTSD. Defining Psychedelics.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

FEBRUARY 28, 2022

Clinical trials are producing promising results, creating enthusiasm for commercializing and patenting psychedelics. 1025, 1026 (2021) (reporting significant improvement of PTSD symptoms following treatment with MDMA in clinical trial); see also Alec J. Mitchell et al., Divito & Robert F. TIMES (Nov.

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

Veriheal

SEPTEMBER 6, 2022

In a systematic review published in 2017 , researchers found that “Preliminary research into cannabis and insomnia suggests that cannabidiol (CBD) may have therapeutic potential for the treatment of insomnia. Clinical trials and placebo-controlled studies are needed to confirm the findings found in this review.

Sleep 108

Sleep THC CBD Chronic Pain 108

The Cannigma

MARCH 12, 2021

And so, they’re trying to standardize, trying to make sure that doctors are are generally coming at problems from a similar perspective, and especially they’re coming at treatments from a similar perspective. MSO: Yeah, it’s very different.

Legalization 130

Legalization Patients Education Dispensary 130

FloridaMarijuana.net

OCTOBER 19, 2018

Persistent physical symptoms that do not respond to treatment, such as headaches, digestive disorders and pain for which no other cause can be determined. The research Men’s Journal is referring to is the 2017 journal article published in Clinical Psychology Review titled: Medical cannabis and mental health: A guided systematic review.

Marijuana 189

Marijuana Research and Development Patients Clinical Trials 189

The Cannigma

OCTOBER 19, 2021

A clinical trial published in 2015 found that the test subjects had “significantly higher blood THC” levels when they used cannabis along with alcohol, and combining the two led to increased performance impairment. The researchers added that people in treatment for AUD might benefit from stopping or reducing their cannabis use.

Research and Development 132

Research and Development Clinical Trials Edibles THC 132

TheAnswerPage

JANUARY 11, 2022

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1). BMC Fam Pract.

Patients 98

Patients Education Marijuana Therapy 98